Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meri

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1992
Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast mediaH J Aronen, L Kivisaari, I Torstila, et al.
FEBS Letters|September 16, 1996
Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti-factor H antibodies: evidence for multiple interactions between H and surface bound C3bT S Jokiranta, P F Zipfel, J Hakulinen, et al.
Immunology|September 1, 1990
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayersS Meri, B P Morgan, A Davies, et al.
Scandinavian Journal of Immunology|September 30, 2000
Splenectomy and adoptive cell transfer reveal a prominent role for splenic memory lymphocytes in the development of chronic relapsing experimental autoimmune encephalomyelitisJ Yang, M Kubera, A Zelek-Molik, et al.
European Journal of Immunology|May 16, 1998
Up-regulated expression of decay-accelerating factor (CD55) confers increased complement resistance to sprouting neural cellsK Z Zhang, S Junnikkala, M G Erlander, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemiaK Ylitalo, P Pajukanta, S Meri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2001
Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infectionsM Seppänen, M L Lokki, T Timonen, et al.
Clinical and Experimental Immunology|February 1, 1991
The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cellsI A Rooney, A Davies, D Griffiths, et al.
Biochemical Society Transactions|November 21, 2002
Factor H family proteins: on complement, microbes and human diseasesP F Zipfel, C Skerka, J Hellwage, et al.
Scandinavian Journal of Immunology|January 30, 2007
Complement and c4 null alleles in severe chronic adult periodontitisM Seppänen, M-L Lokki, I-L Notkola, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1992
Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast mediaH J Aronen, L Kivisaari, I Torstila, et al.
FEBS Letters|September 16, 1996
Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti-factor H antibodies: evidence for multiple interactions between H and surface bound C3bT S Jokiranta, P F Zipfel, J Hakulinen, et al.
Immunology|September 1, 1990
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayersS Meri, B P Morgan, A Davies, et al.
Scandinavian Journal of Immunology|September 30, 2000
Splenectomy and adoptive cell transfer reveal a prominent role for splenic memory lymphocytes in the development of chronic relapsing experimental autoimmune encephalomyelitisJ Yang, M Kubera, A Zelek-Molik, et al.
European Journal of Immunology|May 16, 1998
Up-regulated expression of decay-accelerating factor (CD55) confers increased complement resistance to sprouting neural cellsK Z Zhang, S Junnikkala, M G Erlander, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemiaK Ylitalo, P Pajukanta, S Meri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2001
Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infectionsM Seppänen, M L Lokki, T Timonen, et al.
Clinical and Experimental Immunology|February 1, 1991
The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cellsI A Rooney, A Davies, D Griffiths, et al.
Biochemical Society Transactions|November 21, 2002
Factor H family proteins: on complement, microbes and human diseasesP F Zipfel, C Skerka, J Hellwage, et al.
Scandinavian Journal of Immunology|January 30, 2007
Complement and c4 null alleles in severe chronic adult periodontitisM Seppänen, M-L Lokki, I-L Notkola, et al.
Pageof 16